The popularity of Viagra initially drove a surge for pharma, however recent developments present a complicated picture for investors. Generic versions are eroding earnings, and ongoing litigation add more risk to the https://jasonxiwb985856.isblog.net/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-investment-58493299